Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment
Background: Cancer patients undergoing chemotherapy often experience chemotherapy-induced peripheral neuropathy (CIPN), which reportedly causes gait disturbances that may increase their risk for falls. The purpose of this study was to investigate whether CIPN is associated with spatial-temporal gait...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2017-12-01
|
| Series: | Journal of Cancer Research and Practice |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2311300616301975 |
| _version_ | 1818198030217641984 |
|---|---|
| author | Timothy F. Marshall Genevieve Pinto Zipp Fortunato Battaglia Rebecca Moss Stephanie Bryan |
| author_facet | Timothy F. Marshall Genevieve Pinto Zipp Fortunato Battaglia Rebecca Moss Stephanie Bryan |
| author_sort | Timothy F. Marshall |
| collection | DOAJ |
| description | Background: Cancer patients undergoing chemotherapy often experience chemotherapy-induced peripheral neuropathy (CIPN), which reportedly causes gait disturbances that may increase their risk for falls. The purpose of this study was to investigate whether CIPN is associated with spatial-temporal gait adaptations and fall risk in post-treatment adult cancer survivors.
Method: This study enrolled 16 subjects between 50 and 70 years of age, including 8 subjects with CIPN and 8 subjects with age and morphologically-matched controls. Gait velocity, step length, step time, base of support, swing time, single support time, and double support time as measured by GAITRite. Fall risk was assessed utilizing the Timed Up and Go (TUG) test.
Results: Overall, gait velocity (110.75 cm/s, SD = 26.79, p = 0.006) was significantly slower, and step length (53.92 cm, SD = 23.55, p = 0.005) was significantly shorter in those subjects with CIPN. Additionally, CIPN participants had a significantly higher TUG Score (12.33 s, SD = 6.25, p = 0.001) compared to the controls (6.62 s, SD = 1.10).
Conclusion: Our investigation suggested that gait speed and step length are key indicators for fall risk. Compared to controls, cancer patients with CIPN may display slower gait velocities, shorter step length, and are at an increased fall risk as indicated by TUG scores. The presence of CIPN appears to increase fall risk, which may easily be assessed in a clinical setting using the TUG test. |
| first_indexed | 2024-12-12T01:59:23Z |
| format | Article |
| id | doaj.art-b2709c726f344757a3d8e4b0735bb254 |
| institution | Directory Open Access Journal |
| issn | 2311-3006 |
| language | English |
| last_indexed | 2024-12-12T01:59:23Z |
| publishDate | 2017-12-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Cancer Research and Practice |
| spelling | doaj.art-b2709c726f344757a3d8e4b0735bb2542022-12-22T00:42:15ZengWolters Kluwer Medknow PublicationsJournal of Cancer Research and Practice2311-30062017-12-014413413810.1016/j.jcrpr.2017.03.005Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatmentTimothy F. Marshall0Genevieve Pinto Zipp1Fortunato Battaglia2Rebecca Moss3Stephanie Bryan4School of Physical Therapy, Kean University, United StatesDepartment of Interprofessional Health Sciences & Health Administration, Seton Hall University, United StatesDepartment of Interprofessional Health Sciences & Health Administration, Seton Hall University, United StatesRutgers, Cancer Institute of New Jersey, United StatesDepartment of Health & Physical Education, Saint Peter’s University, United StatesBackground: Cancer patients undergoing chemotherapy often experience chemotherapy-induced peripheral neuropathy (CIPN), which reportedly causes gait disturbances that may increase their risk for falls. The purpose of this study was to investigate whether CIPN is associated with spatial-temporal gait adaptations and fall risk in post-treatment adult cancer survivors. Method: This study enrolled 16 subjects between 50 and 70 years of age, including 8 subjects with CIPN and 8 subjects with age and morphologically-matched controls. Gait velocity, step length, step time, base of support, swing time, single support time, and double support time as measured by GAITRite. Fall risk was assessed utilizing the Timed Up and Go (TUG) test. Results: Overall, gait velocity (110.75 cm/s, SD = 26.79, p = 0.006) was significantly slower, and step length (53.92 cm, SD = 23.55, p = 0.005) was significantly shorter in those subjects with CIPN. Additionally, CIPN participants had a significantly higher TUG Score (12.33 s, SD = 6.25, p = 0.001) compared to the controls (6.62 s, SD = 1.10). Conclusion: Our investigation suggested that gait speed and step length are key indicators for fall risk. Compared to controls, cancer patients with CIPN may display slower gait velocities, shorter step length, and are at an increased fall risk as indicated by TUG scores. The presence of CIPN appears to increase fall risk, which may easily be assessed in a clinical setting using the TUG test.http://www.sciencedirect.com/science/article/pii/S2311300616301975CancerChemotherapyPeripheral neuropathyFallsGait |
| spellingShingle | Timothy F. Marshall Genevieve Pinto Zipp Fortunato Battaglia Rebecca Moss Stephanie Bryan Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment Journal of Cancer Research and Practice Cancer Chemotherapy Peripheral neuropathy Falls Gait |
| title | Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment |
| title_full | Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment |
| title_fullStr | Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment |
| title_full_unstemmed | Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment |
| title_short | Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment |
| title_sort | chemotherapy induced peripheral neuropathy gait and fall risk in older adults following cancer treatment |
| topic | Cancer Chemotherapy Peripheral neuropathy Falls Gait |
| url | http://www.sciencedirect.com/science/article/pii/S2311300616301975 |
| work_keys_str_mv | AT timothyfmarshall chemotherapyinducedperipheralneuropathygaitandfallriskinolderadultsfollowingcancertreatment AT genevievepintozipp chemotherapyinducedperipheralneuropathygaitandfallriskinolderadultsfollowingcancertreatment AT fortunatobattaglia chemotherapyinducedperipheralneuropathygaitandfallriskinolderadultsfollowingcancertreatment AT rebeccamoss chemotherapyinducedperipheralneuropathygaitandfallriskinolderadultsfollowingcancertreatment AT stephaniebryan chemotherapyinducedperipheralneuropathygaitandfallriskinolderadultsfollowingcancertreatment |